Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00373568
Status:
COMPLETED
Last Update Posted:
2010-06-02
First Post:
2006-09-07
Brief Title:
Miltefosine Long Course for Bolivian Mucosal Leishmaniasis
Sponsor:
AB Foundation
Organization:
AB Foundation
Study Overview
Official Title:
Miltefosine 42 Days for Mucosal Leishmaniasisi
Status:
COMPLETED
Status Verified Date:
2010-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Miltefosine longer course will be used to try to improve the cure rate of mucosal leishmaniasis
Detailed Description:
Miltefosine 42 days will be used to try to improve upon the cure rate with 28 days of drug for bolivian mucosal leishmaniasisi
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None